Genmab — Oktober 2019

E_L

sure @Solsen, and if other biotech news can get Bio out of it's 4+ years of depression that can help as well

E_L

I actually think Q4 Dara numbers will be very good and will impact price before the end of the year - before WE actually know any sales numbers, larger investors will figure it out...

Solsen

Perhaps prescriptions from oct and nov can do it

Solsen

The smell from a coming partnerdeal could also have an influence.

E_L

hopefully

Bella1

Smells good...

Solsen

The report from UBS made oct 10. has a forecast on dara sales for 2019 on $3.002 bn

Bulder

I don't think we'll have any surprises. Somewhere between 3 and 3,1 bn.

Bulder

My own guess: 440+405=845 q4 = 3.013 fy

Bulder

But very interesting will be the 2020 guidance.

E_L

yes, i have a feeling the range of dara analyst
projections for 2020 is rather large. I think I have seen between 3.5 and 4.1 so far

E_L

(which i think is rather conservative...)

Doublo

2 resultater
1-10
OVERSKRIFT OG VIRKSOMHED TYPE TIDSPUNKT
AQR Capital Management, LLC holds a short position at 1.19 % in shares issued by Genmab A/S
Genmab A/S
Shortselling 16.10.2019
kl.14:58:43
Marshall Wace LLP holds a short position at 0.51 %

Bulder

Bowers and Novod says 4.146 and 4.202 respectively. I say 4.300

JKY_VH

Du plejer at være spot on Bulder, så den køber jeg:-)

Solsen

UBS have $4.027bn. I belive Bulder !

Helge_LarsenPI-redaktør

Farvel til Radio24/7 og Millionærklubben. https://www.proinvestor.com/debat/78230

transalp

Det er op ad bakke med den medie løsning.. noget der har fundet sin form, høj kvalitet og stor opbakning skal smadres, af tvivlsomme politiske grunde.. IMHO

bibob

@helge. Der er desværre for meget politik ifm. med,medierne. Men nu hvor du har lavet din egen morgenbriefing, og virkelig " bruger extra tid " på dette forum , og kommer med " Breaking news ". Synes jeg også at en Breaking donation vil være på sin plads. ;-). Den vil komme på mob.pay i morgen. Tak for et kanon good forum.

Plimsoller

God morgen